Whether infertile women exhibit accelerated ovarian aging and whether a low ovarian reserve is overrepresented in infertility populations is not known.
R
eproductive aging is underpinned by concurrent depletion of the follicular pool and a decline in oocyte quality (1) . Composite models of the number of nongrowing follicles (NGF) that constitute the ovarian reserve from birth to menopause expose substantial variation between individuals (2, 3). It is unknown whether, with the postponement of parenthood and increased maternal age, biological variation in the ovarian reserve may also contribute to the increased prevalence of infertility.
Despite the ovarian reserve being a critical determinant of reproductive milestones such as the age of optimal fertility, sterility, and menopause (4 -8) , it cannot be readily assessed. Several biomarkers that correlate numerically or physiologically with NGF have been proposed as surrogates (3, 9 -11) . Only antral follicle count (AFC) and antiMüllerian hormone (AMH) exhibit strong associations with histologically determined NGF number and functional measures of the ovarian reserve such as ovarian response to stimulation (12) . The age-related decline in AMH has been well established (13) (14) (15) ; however, comparison of ovarian aging between fertile and nonfertile populations has been constrained due to ongoing assay development and the lack of standardization (12) .
For AFC, development of age-specific population reference ranges has been limited primarily due to the invasive nature of transvaginal ultrasound for known fertile healthy populations, and secondly due to inconsistencies in the technical aspects of AFC measurement (12) . The latter has recently been resolved with the publication of a consensus statement setting the technical standards of AFC measurement (16) , whereas the former limitation has yet to be tackled. Small single-center studies (n ϭ 362 to 1866) have reported a negative association between age and AFC (17) (18) (19) . However, these models were developed from small single-site studies of fertile women (n ϭ 362, Ref. To examine whether reproductive aging is similar between fertile and nonfertile women, we sought to develop, compare, and validate population models describing the agerelated decline in AFC in women without a history of infertility (potential oocyte donors) as compared to women seeking fertility treatment.
Subjects and Methods

Study design and participants
A prospective cross-sectional study was conducted in 13 IVI infertility centers across Spain from January 2013 to December 2014. Consecutive women attending the clinics either for fertility treatment or as potential oocyte donors were included in the study. In Spain, ovum donation is anonymous. Donors must be between 18 and 35 years old, be healthy and without a family history of inherited or chromosomal conditions, and have normal gynecological examination results and a negative screening for infectious diseases. The overall analysis was restricted to women aged 18 to 45 years without missing AFC data because reproductive indicators vary substantially at the extremes of reproductive age. Collected data were anonymized, and each patient was allocated a unique identifier number. Demographic and lifestyle information was self-reported. The vast majority of the women were of white European descent.
AFC measurement
All patients underwent standardized AFC assessment at day 2 to 4 of their cycle in accordance with recent consensus statements (16) . All ultrasound scans were performed by medical personnel appropriately trained in transvaginal sonography with the use of identical equipment at all sites incorporating a 7-10 MHz probe (Voluson 730 Expert; GE Healthcare). Only follicles measuring 2-10 mm in diameter were included in the AFC. AFC measurements were subject to routine quality control measurements.
Statistical analysis
Datasets from the different centers were merged, and cases with missing age or AFC information were excluded. AFC was compared between oocyte donors and infertile women for different age bands. The relationship of AFC to age was modeled separately for donors and infertility patients by predicting the log-transformed AFC values from a penalized thin-plate regression spline of age (22) . The smoothing parameter was estimated using generalized cross-validation.
Model fit was assessed and validated through a 5-fold crossvalidation. The root mean square error (RMSE) was calculated to summarize the model fit. The RMSE is the sample standard deviation of the difference between the observed values and the values predicted by the model. It is a measure of accuracy where zero would be perfect accuracy of the prediction. Reference plots for donors and infertility patients were generated showing predicted percentiles for AFC by age. Prediction intervals were calculated assuming a normal distribution of the residuals for log AFC and then transformed back on the original scale.
Sensitivity analysis was performed to assess whether cycle irregularity (women were stratified to those with regular cycles of between 25 and 35 days, shorter cycles of Ͻ25 days, and longer cycles of Ͼ35 days) or different percentiles of AFC modify the decline of AFC with advancing age. We also checked whether different operators modify the association between AFC and age by assessing the significance of the interaction term, including the operator variable in the model at the conventional level of P Ͻ .05.
All analyses were performed using R version 3.0.1 (23) .
Results
Population
A total of 15 500 women between 18 to 45 years of age with a valid AFC measurement were included in the analyses; 5722 were potential oocyte donors, and the remaining 9778 were patients seeking fertility treatment. Table 1 shows the demographic characteristics of the cohort stratified to potential oocyte donors and infertility patients. Potential oocyte donors were younger than the infertile women (25. 16, 24) , vs 10 (IQR, 6, 15); P Ͻ .001-a difference that was maintained after adjustment for age (P Ͻ .001 in model predicting log (AFC) from donor vs infertility, adjusting for 2-year age bands). Table 2 shows the AFC in potential oocyte donors and infertility patients stratified by age; the potential oocyte donors have substantially greater AFC for any given age over 25 years compared with the infertility patients of similar age. Hence, the discrepancy in the average AFC between potential oocyte donors and infertility patients is not driven by the age difference between the two groups. Figure 1 shows the average decline in AFC across all ages for potential oocyte donors and infertility patients. The decline of AFC with age was substantially steeper in women with a history of infertility than in potential oocyte donors for the comparable age range up to 35 years. Supplemental Figure 1 shows the decline in AFC in potential oocyte donors and infertility patients for different percentiles of AFC, demonstrating that for AFC Ն25th percentile for each group, the rate of decline of AFC becomes steeper with advancing age in the infertility patients compared with the oocyte donors. The dashed continuation of the line for potential oocyte donors for ages over 35 years was based on model extrapolation. The RMSEs for potential oocyte donors and infertility patients were 0.32 and 0.62, respectively. In the analysis comparing AFC in donors with infertile women, the interaction term including the operator variable was not significant to the conventional level of P Ͻ .05 (P ϭ .31), which means that operatordependent variation in AFC did not modify substantially the associations between AFC and study groups; hence, stratification of the analysis per operator was not warranted. Figure 2 , A and B, demonstrates the reference plots of AFC relative to age for potential oocyte donors and infertility patients, respectively. The wide solid line shows the predicted median AFC value along with aging, whereas the thin solid lines show different prediction percentiles as labeled. Gray shading and dashed lines in the reference plot for donors indicate extrapolated results beyond the maximum age of 35 years in our dataset. Supplemental Figure 2 shows that the rate of decline of AFC with age in women with regular, short, or long cycles does not differ substantially in either potential oocyte donors or infertility patients.
Age-related decline in AFC
Prevalence of low AFC within infertile women and women without a history of infertility
International consensus has defined a low ovarian reserve as an AFC Ͻ 5 (24). Figure 2 demonstrates that among infertile women, 1, 5, and 10% of the population at the ages of 20, 30, and 35 years, respectively, had low AFC. However, among potential oocyte donors, Ͻ1% of the women had low AFC at the ages of 20, 30, or 35 years. Hence, low ovarian reserve assessed with AFC is more prevalent among infertile women from almost the age of 20 to at least the age of 35 years.
Discussion
To our knowledge, this is the largest study (n ϭ 15 500) to evaluate the age-related decline in ovarian reserve assessed by AFC in both potential oocyte donors and infertility patients and to generate age-related reference ranges of AFC that will be valuable in clinical practice. Furthermore, we confirmed the prevailing assumption that women with low ovarian reserve are overrepresented within infertile populations that exhibit a greater decline in AFC with aging compared with women without a history of infertility. In addition, subgroup analysis demonstrated that the decline in AFC in the infertility group was steeper almost universally, irrespective of the percentile AFC or cycle length. The age-related decline in AFC has been modeled before in smaller samples of infertile (n ϭ 1866, Ref. 21) or fertile (n ϭ 362, Ref. 17; or n ϭ 366, Ref. 19 ) women, suggesting a biphasic or linear decline in AFC with aging, respectively. Our study in substantially larger populations and by using refined statistical methodology departs from the concept of the exponential decline model and suggests a smoother decline in AFC in, at least, infertile patients that mirrors the decline in NGF recruitment, the process that feeds AFC (2) . This further supports the physiological connection between AFC, NGF, and ovarian reserve and grants biological plausibility to our model. The splinemodeled decline in AFC in the population of potential oocyte donors, who represent women of normal fertility potential (n ϭ 5722), was closer to the linear model in line with the smaller studies in fertile women (17, 19) . However, we acknowledge that the model may have deviated from linearity if women over the age of 35 years, almost at the age when NGF recruitment slows down and plateaus (2), were represented in this group.
In comparison with the previously published normograms (17, 18), our average predicted AFC for any given age was higher for both fertile and infertile women. This numerical discrepancy may be attributed mainly to the contemporary nature of our study and the associated technical advancement in transvaginal sonography, enabling practitioners to visualize and thereby quantify a larger number of follicles (25) . Similarly, the reference ranges of AFC for oocyte donors suggest that up to the age of 35 years, at least 25% of the women would have polycystic ovary (PCO) morphology based on the 2003 Rotterdam criteria (26) , whereas with the recommendations of most recent studies suggesting that PCO morphology should be defined as having at least 25 follicles per ovary (hence, AFC of at least 50) (25, 27) , a small proportion of them would be classified as having PCO appearance. Our data would suggest that an upward shift of the normal AFC range is required, possibly due to technical advancements in sonography, and provide further support for the need to redefine PCO morphology (27) . However, we cannot exclude the possibility that the small proportion of women with PCO appearance in the oocyte donor group may imply a unique self-selected group that is not entirely representative of the general population.
Women with infertility demonstrated a steeper age-related decline in their AFC compared with potential oocyte donors, despite both groups having an almost identical starting point in their ovarian reserve at the age of 18 years. Whether this is mainly a result of overrepresentation of women with low ovarian reserve among infertile patients, especially in the second half of their reproductive lifespan, or this indicates an additional accelerated ovarian aging and thereby earlier menopause (6) in women with infertility is unclear. Our findings are in keeping with a previous smaller study (n ϭ 881 infertile women, n ϭ 771 controls) indicating a substantial discrepancy in ovarian reserve between infertile women and women without a history of infertility and provides further evidence for the dominant theory that follicular pool depletion contributes to female infertility (20) . Prospective longitudinal data are warranted to clarify the source of the discrepancy in AFC decline between the two populations.
Our age-specific normograms resulted from robust modeling and cross-validation methodology and generated age reference ranges of AFC for both infertile and fertile populations of white descent. Normograms have great clinical value and can be used by clinicians for a pictorial representation of AFC range when consulting patients. This would enable patients to comprehend where their ovarian reserve stands within the normal range for their age and grasp the concept of percentile curves. Given that AFC has been suggested as a potential predictor of the age of menopause (28) or loss of fertility (6), age-related normograms can demonstrate more clearly to lay people why a woman in the lowest percentile curves of AFC is more likely to have a depleted ovarian reserve pool and thereby reach her natural sterility or menopause at a younger age compared with the average background population.
The major strengths of our study are a large number of prospective oocyte donors and infertility patients, standardized ultrasound methodology, and sophisticated statistical analyses. The large sample size in each arm enables an accurate representation of the distribution of AFC for any given age along the reproductive lifespan by eliminating the risk of incorrect model fitting due to inadequate data points. Spline modeling allows flexibility and avoids overfitting of a model; hence, it approximates the actual relationship between two variables more accurately, compared with simple or polynomial regression (29) . In addition, cross-validation limits the problem of data overfitting and provides additional reassurance that the fitted models will perform well in independent datasets (29) . Both groups, infertile women and oocyte donors, attended the clinics contemporarily, and similar sonographic methodology was used, enabling direct comparison of AFC between the two groups and minimizing the possibility of measurement bias. In addition, similar protocols in data collection and AFC assessment were applied across all the participating reproductive centers, eliminating intercenter variation. We acknowledge that AFC measurement is subject to intra-and interobserver variation, which may have an impact on assessing ovarian reserve at an individual level (30) . However, at a population level, operator-de-pendent variation is less of an issue because the age-related normogram of AFC captures the AFC variation for any given age, which can also be subject to different factors. In addition, we showed that operator variation did not modify the associations between AFC and age; hence, stratification of the analysis per operator was not warranted. We acknowledge that the cross-sectional nature of our AFC data limits the potential for longitudinal extrapolation of the normograms; however, the large sample size compensates partially for this. Undoubtedly, longitudinal data and fitting of our models to external populations would provide additional validity to our findings. We cannot exclude that some of the oocyte donors may have been on the contraceptive pill during their AFC assessment. However, because long-term use of the contraceptive pill decreases AFC (31, 32) , this would only attenuate any observed differences between oocyte donors and infertile women. Similarly, the greater prevalence of smoking observed among the oocyte donors compared to the infertility patients would have attenuated, rather than explaining, the discrepancy in AFC among the two populations. Lastly, the AFC for the oocyte donors was determined before acceptance to the donation program, rendering the generalizability of the data to normal healthy populations acceptable. However, we acknowledge that oocyte donors may represent a self-selected group that is not entirely representative of the general population. In particular, their observed low rate of age-related decline in AFC may have exaggerated the discordance between them and the infertile women. Hence, validation of the normogram in the general population is warranted.
We conclude that AFC declines with advancing age in both potential oocyte donors and infertile women. The extent of the decline is substantially larger in infertile women, potentially reflecting that women with low ovarian reserve are overrepresented within the infertile population. We have generated age-related reference ranges of AFC for both populations that can be valuable tools in clinical settings and facilitate patient consultation. Longitudinal data and external validation would add extra weight to our results.
